← Back to Search

Artificial Pancreas System

Control-IQ technology 1.5 for Type 2 Diabetes (2IQ Trial)

N/A
Waitlist Available
Led By Carol Levy, MD
Research Sponsored by Tandem Diabetes Care, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 weeks
Awards & highlights

2IQ Trial Summary

This study is evaluating whether a home-based system can help people with type 2 diabetes control their blood sugar levels.

Eligible Conditions
  • Type 2 Diabetes

2IQ Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
CGM Time Above 180 mg/dL
CGM Time Below 54 mg/dL
Secondary outcome measures
CGM Mean Glucose mg/dL
CGM Time Above 250 mg/dL
CGM Time Below 70 mg/dL
+3 more
Other outcome measures
All Serious Adverse Events
DKA
Hyperosmolar Hyperglycemic Syndrome
+2 more

2IQ Trial Design

2Treatment groups
Experimental Treatment
Group I: Multiple Daily Injections (Group B)Experimental Treatment1 Intervention
2 to 4 week CGM run-in 2 to 4 week pump run-in 6 weeks Control-IQ technology use
Group II: Basal Insulin Only (Group A)Experimental Treatment1 Intervention
2 to 4 week CGM run-in 2 to 4 week pump run-in 6 weeks Control-IQ technology use
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Control-IQ technology 1.5
2021
N/A
~30

Find a Location

Who is running the clinical trial?

Tandem Diabetes Care, Inc.Lead Sponsor
37 Previous Clinical Trials
5,657 Total Patients Enrolled
Jaeb Center for Health ResearchOTHER
152 Previous Clinical Trials
34,639 Total Patients Enrolled
Carol Levy, MDPrincipal InvestigatorIcahn School of Medicine at Mt. Sinai
2 Previous Clinical Trials
35 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
New York
Texas
How old are they?
65+
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Control-IQ Technology in Individuals With Type 2 Diabetes
2021. "Control-IQ Technology in Individuals With Type 2 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05111301.
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top